2010•Unpublished venueRequires access

The detection of diverse tumor markers to lung carcinoma metastasis and prognosis evaluation

Gu Yan

Open publisher page 0 citations

Abstract

Objective:To investigate the combined detection of diverse tumor markers to lung carcinoma metastasis and the value of prognosis evaluation.Methods:The blood serum of 117 patients with lung carcinoma were detected by diverse tumor markers protein biochip for determining the level of 12 kinds of tumor markers(AFP,NSE,CEA,CA125,CA199,CA242,CA153,ferritin,free-PSA,PSA,β-HCG and HCG) in the blood,and in those cases,88 cases were identified as metastasis group and 29 as non-metastasis group,and prognosis was followed up.Results:The positive rate of metastasis group was 67.1%(59/88),which was evidently higher than the rate of non-metastasis 27.6%(8/29)(P=0.0002) ;after 2-year's follow-up,it was found that the death rate of patients with positive tumor markers was 95.31%(61/64),which was evidently higher than the negative group 55.56%(25/45)(P=0.0000).Conclusion:The combined detection of tumor markers can be used as index of clinical criterion of lung carcinoma metastasis,and that is significant to prognosis evaluation.

About this research paper

What this paper is about

Objective:To investigate the combined detection of diverse tumor markers to lung carcinoma metastasis and the value of prognosis evaluation.Methods:The blood serum of 117 patients with lung carcinoma were detected by diverse tumor markers protein biochip for determining the level of 12 kinds of tumor markers(AFP,NSE,CEA,CA125,CA199,CA242,CA153,ferritin,free-PSA,PSA,β-HCG and HCG) in the blood,and in those cases,88 cases were identified as metastasis group and 29 as non-metastasis group,and prognosis was followed up.Results:The positive rate of metastasis group was 67.1%(59/88),which was evidently higher than the rate of non-metastasis 27.6%(8/29)(P=0.0002) ;after 2-year's follow-up,it was found that the death rate of patients with positive tumor markers was 95.31%(61/64),which was evidently higher than the negative group 55.56%(25/45)(P=0.0000).Conclusion:The combined detection of tumor markers can be used as index of clinical criterion of lung carcinoma metastasis,and that is significant to prognosis evaluation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the combined detection of diverse tumor markers to lung carcinoma metastasis and the value of prognosis evaluation.Methods:The blood serum of 117 patients with lung carcinoma were detected by diverse tumor markers protein biochip for determining the level of 12 kinds of tumor markers(AFP,NSE,CEA,CA125,CA199,CA242,CA153,ferritin,free-PSA,PSA,β-HCG and HCG) in the blood,and in those cases,88 cases were identified as metastasis group and 29 as non-metastasis group,and prognosis was followed up.Results:The positive rate of metastasis group was 67.1%(59/88),which was evidently higher than the rate of non-metastasis 27.6%(8/29)(P=0.0002) ;after 2-year's follow-up,it was found that the death rate of patients with positive tumor markers was 95.31%(61/64),which was evidently higher than the negative group 55.56%(25/45)(P=0.0000).Conclusion:The combined detection of tumor markers can be used as index of clinical criterion of lung carcinoma metastasis,and that is significant to prognosis evaluation.

Key concepts: Medicine, Metastasis, Internal medicine, Lung, Carcinoma, Tumor marker, Oncology, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
The detection of diverse tumor markers to lung carcinoma metastasis and prognosis evaluation — Research Paper | ScholarLens